Additionally, we injected DT in combination with anti-PD-1 antibody to assess synergistic effects of Treg-derived CD27 with concomitant blockade of the PD-1 signaling pathway on CD8+ T cell numbers and effector functions within the tumor. This evidence concerns the gene CD8A and neoplasm.